Literature DB >> 9756053

Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1).

H R Kranzler1, J Gelernter, S O'Malley, C A Hernandez-Avila, D Kaufman.   

Abstract

Opioidergic neurotransmission and, specifically, the mu opioid receptor have been implicated in the reinforcing effects of a variety of drugs of abuse. Consequently, the present study examined the association of a polymorphic (CA)n repeat at the OPRM1 locus (the gene coding for the mu opioid receptor) to alcohol or drug dependence in 320 Caucasian and 108 African-American substance-dependent or control subjects. Among Caucasians, suggestion of a modest association, which could be interpreted as statistically significant (p = 0.03), was observed between OPRM1 alleles and substance (alcohol, cocaine, or opioid) dependence. Analysis by specific substance showed only a trend level association to alcohol dependence. Comparisons among African Americans yielded no evidence for association. Further studies of the association between alleles of the OPRM1 gene and substance dependence appear warranted, particularly if they use a family-based approach to control for population stratification. Phenotypes other than a broad diagnostic categorization, such as opioid antagonist effects on drinking behavior in alcoholics, may provide more consistent evidence of a role for OPRM1 in behavioral variability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756053

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  20 in total

Review 1.  Genetic studies of alcoholism and substance dependence.

Authors:  T Reich; A Hinrichs; R Culverhouse; L Bierut
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.

Authors:  Huiping Zhang; Xingguang Luo; Henry R Kranzler; Jaakko Lappalainen; Bao-Zhu Yang; Evgeny Krupitsky; Edwin Zvartau; Joel Gelernter
Journal:  Hum Mol Genet       Date:  2006-02-13       Impact factor: 6.150

Review 3.  Pharmacogenetics of OPRM1.

Authors:  Richard C Crist; Wade H Berrettini
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

Review 4.  Genetic approaches to addiction: genes and alcohol.

Authors:  Francesca Ducci; David Goldman
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

Review 5.  The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Authors:  Lara A Ray; Christina S Barr; Julie A Blendy; David Oslin; David Goldman; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

Review 6.  Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism.

Authors:  Lara A Ray; James Mackillop; Peter M Monti
Journal:  Subst Use Misuse       Date:  2010-09       Impact factor: 2.164

7.  Convergent Balancing Selection on the Mu-Opioid Receptor in Primates.

Authors:  Carolyn G Sweeney; Juliette M Rando; Helen N Panas; Gregory M Miller; Donna M Platt; Eric J Vallender
Journal:  Mol Biol Evol       Date:  2017-07-01       Impact factor: 16.240

Review 8.  OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.

Authors:  Stephen D Mague; Julie A Blendy
Journal:  Drug Alcohol Depend       Date:  2010-01-13       Impact factor: 4.492

Review 9.  Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?

Authors:  F Scott Hall; Jana Drgonova; Siddharth Jain; George R Uhl
Journal:  Pharmacol Ther       Date:  2013-07-18       Impact factor: 12.310

10.  Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.

Authors:  Albert J Arias; Stephen Armeli; Joel Gelernter; Jonathan Covault; Antero Kallio; Sakari Karhuvaara; Tiina Koivisto; Rauno Mäkelä; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.